Christopher R. Gordon, Director, 10% Owner at Cerevel Therapeutics Holdings, Inc. (CERE), bought 664,586 shares at $10.30 ($6.8M) on 2020-11-09, disclosed to the SEC on 2020-11-12.
Open-market purchase of $6.8M CERE by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.30 | 332,293 | $3.4M | 50.0% |
| 2 | $10.30 | 332,293 | $3.4M | 50.0% |
| Total | $10.30 avg | 664,586 | $6.8M | 100% |
| Filing → |
| ACHC | SELL | 2017-08-24 | $101.2M | — | Filing → |
| ACHC | SELL | 2017-08-02 | $253.5M | — | Filing → |
| ACHC | SELL | 2015-08-18 | $189.2M | — | Filing → |